NSE · Healthcare · Biotechnology
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 LYKA LABS LIMITED – Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Standalone Revenue from Operations (Q1 FY27): Rs 12,090.53 lakhs (unaudited) • | 2026-08-10 |
| Quarterly results · Q4 FY26 LYKA LABS LIMITED - DOCUMENT SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Major Write-off: Impairment loss of Rs. 2,301.44 lakhs recognized on in | 2026-05-25 |
| Quarterly results · Q3 FY26 LYKA LABS LIMITED – Q3 FY2025-26 RESULTS SUMMARY HEADLINE NUMBERS STANDALONE BASIS (Q3 ended 31st December 2025) • Revenue from Operations: ₹13,469. | 2026-01-29 |
| Quarterly results · Q2 FY26 LYKA LABS LIMITED - FINANCIAL SUMMARY Half Year Ended 30th September 2025 --- HEADLINE NUMBERS STANDALONE RESULTS (Half Year) • Revenue from Operat | 2025-11-12 |
| Quarterly results · Q1 FY26 LYKA LABS LIMITED – BOARD MEETING SUMMARY (1st August 2025) HEADLINE NUMBERS • Quarter Ended: 30th June 2025 • Financial Results Status: Unaudited s | 2025-08-01 |
| Annual report FY2025 LYKA LABS LIMITED - ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Revenue from operations: Rs 12,963.00 lakhs (FY 2025) vs Rs 10,149.93 lakhs (FY 2024) — | 2025-07-08 |
| Quarterly results | 2025-02-04 |
| Quarterly results | 2024-11-12 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lyka Labs Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.